Ocugenix Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4M
- Investors
-
2
Ocugenix General Information
Description
Developer of disease-modifying ophthalmic therapies intended to treat angiofibrotic diseases of the eye. The company offers wet macular degeneration therapies, geographic atrophy treatments, proliferative diabetic retinopathy drugs, dry eye disease therapeutics, and ocular small molecule candidates, enabling patients to restore homeostatic function and prevent vision loss by activating natural wound-healing processes.
Contact Information
Website
www.ocugenix.comCorporate Office
- 79 Woodland Road
- Pittsburgh, PA 15232
- United States
Corporate Office
- 79 Woodland Road
- Pittsburgh, PA 15232
- United States
Ocugenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 21-Mar-2022 | $4M | Completed | Clinical Trials - Phase 2 | ||
| 1. Seed Round | 29-Mar-2017 | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ocugenix Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mountain State Capital | Venture Capital | Minority | ||
| Innovation Works | Venture Capital | Minority |
Ocugenix FAQs
-
When was Ocugenix founded?
Ocugenix was founded in 2015.
-
Where is Ocugenix headquartered?
Ocugenix is headquartered in Pittsburgh, PA.
-
What industry is Ocugenix in?
Ocugenix’s primary industry is Drug Discovery.
-
Is Ocugenix a private or public company?
Ocugenix is a Private company.
-
What is Ocugenix’s current revenue?
The current revenue for Ocugenix is .
-
How much funding has Ocugenix raised over time?
Ocugenix has raised $4.1M.
-
Who are Ocugenix’s investors?
Mountain State Capital and Innovation Works have invested in Ocugenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process